Treatment options from the etiological classification of depression may include gene therapy to rescue intestinal 5-HTP cells or enhance peripheral 5-HTP production and thereby compensate for TPH1 dysfunction, psychotherapy for TDO activation, and anti-inflammatory drugs for IDO activation. This evidence concerns the gene IDO1 and major depressive disorder.